Cargando…
Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961090/ https://www.ncbi.nlm.nih.gov/pubmed/31898629 http://dx.doi.org/10.4103/lungindia.lungindia_291_19 |
| _version_ | 1783487920255008768 |
|---|---|
| author | Thakur, Sayanta Chakraborty, Dwaipayan Sarathi Lahiry, Sandeep Choudhury, Shouvik |
| author_facet | Thakur, Sayanta Chakraborty, Dwaipayan Sarathi Lahiry, Sandeep Choudhury, Shouvik |
| author_sort | Thakur, Sayanta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6961090 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69610902020-01-16 Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario Thakur, Sayanta Chakraborty, Dwaipayan Sarathi Lahiry, Sandeep Choudhury, Shouvik Lung India Research Letters Wolters Kluwer - Medknow 2020 2019-12-31 /pmc/articles/PMC6961090/ /pubmed/31898629 http://dx.doi.org/10.4103/lungindia.lungindia_291_19 Text en Copyright: © 2019 Indian Chest Society http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Research Letters Thakur, Sayanta Chakraborty, Dwaipayan Sarathi Lahiry, Sandeep Choudhury, Shouvik Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario |
| title | Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario |
| title_full | Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario |
| title_fullStr | Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario |
| title_full_unstemmed | Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario |
| title_short | Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario |
| title_sort | osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: opportunities and challenges in indian scenario |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961090/ https://www.ncbi.nlm.nih.gov/pubmed/31898629 http://dx.doi.org/10.4103/lungindia.lungindia_291_19 |
| work_keys_str_mv | AT thakursayanta osimertinibasanemergingtherapeuticmodalityinnonsmallcelllungcanceropportunitiesandchallengesinindianscenario AT chakrabortydwaipayansarathi osimertinibasanemergingtherapeuticmodalityinnonsmallcelllungcanceropportunitiesandchallengesinindianscenario AT lahirysandeep osimertinibasanemergingtherapeuticmodalityinnonsmallcelllungcanceropportunitiesandchallengesinindianscenario AT choudhuryshouvik osimertinibasanemergingtherapeuticmodalityinnonsmallcelllungcanceropportunitiesandchallengesinindianscenario |